Core Viewpoint - A long-standing divorce property dispute involving significant assets and control of a listed company has concluded, resulting in a change of actual control over Wohuamedicine [1][3]. Company Control Change - The court's ruling mandates an equal division of shares in Zhongzheng Wanrong Investment Group, the controlling shareholder of Wohuamedicine, between Zhao Bingxian and his ex-wife Lu Juan, changing the actual control of Wohuamedicine to a state of no actual controller [3][12]. - Zhao Bingxian previously held 80% of Zhongzheng Wanrong, while Lu Juan held 20%. Post-division, both will hold 50% each [3][12]. - The value of the shares transferred to Lu Juan is approximately 547 million yuan, based on Wohuamedicine's market capitalization of 3.648 billion yuan as of November 10, 2025 [3][12]. Company Background - Wohuamedicine, established in 2002 and listed in 2007, specializes in the research, production, and sales of natural plant-based cardiovascular traditional Chinese medicine [12]. - The company's core products include Wohuaxin Keshupian, Gushukang capsules/particles, Huo Dan tablets/capsules, and Naoxue Shukouye, which are the main sources of its revenue and profit [12]. Financial Performance - Wohuamedicine has faced declining performance in recent years, with a continuous drop in net profit from 2021 to 2024 due to price reductions of core products and high marketing costs [12][13]. - The revenue from Wohuaxin Keshupian decreased by 22.56% in 2024, significantly impacting overall revenue [13]. - However, there was a turnaround in 2025, with a reported revenue of 625 million yuan, an increase of 8.31%, and a net profit of 63.995 million yuan, up 179.34% year-on-year [13]. Shareholder Dynamics - The number of shareholders in Wohuamedicine decreased from 48,021 to 34,476 between Q1 2021 and Q1 2025, but began to stabilize and increase to 41,003 by September 30, 2025 [13]. - Following the court ruling, Wohuamedicine's stock price remained stable, with slight increases observed after the announcement [14]. Future Outlook - Lu Juan expressed her commitment to improving management and governance within the company, emphasizing the importance of a professional management team and internal governance mechanisms for sustainable development [14]. - She plans to convene a shareholders' meeting to discuss the company's governance and development direction [14].
A股又一天价离婚案,女方分走超5亿,中国巴菲特失去实控权